PRKAR1A mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 6, 2006, Pages 2380-2388

  Robinson White, Audrey ^a   Meoli, Elise ^a   Stergiopoulos, Sotirios ^a   Horvath, Anelia ^a   Boikos, Sosipatros ^a   Bossis, Ioannis ^a   Stratakis, Constantine A ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b Section on Endocrinology and Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYC PROTEIN; PROTEIN KINASE B; PROTEIN PRKAR 1A; UNCLASSIFIED DRUG;

ADRENAL CORTEX; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION;

ADRENAL CORTEX; ADULT; CHILD; CHILD, PRESCHOOL; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; MUTATION; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 33744955546     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0188     Document Type: Article

References (40)

1. Stratakis CA, Kirschner LS 1998 Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing syndrome. Horm Metab Res 30:456-463
2. Stratakis CA, Kirschner LS, Carney JA 2001 Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 86:4041-4046
3. Stergiopoulos SG, Stratakis CA 2003 Human tumors associated with Carney complex and germline. PRKAR1A mutations: a protein kinase A disease! FEBS Lett 546:59-64
4. Kirschner LS, Sandrini F, Monbo J, Jing-Ping L, Carney JA, Stratakis CA 2000 Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex. Hum Mol Genet 9:3037-3046
5. Groussin L, Jullian E, Perlemoine K, Louvel A, Leheup B, Luton JP, Bertagna X, Bertherat J 2002 Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease. J Clin Endocrinol Metab 87:4324-4329
6. Kirschner LS, Carney JA, Pack S, Tayman SE, Cho YS, Cho-Chung Y, Stratakis CA 2000 Mutations in the gene encoding the type 1α regulatory subunit of the protein kinase A (PRKAR1A) in patients with Carney complex. Nat Genet 26:89-92
7. Griffin KJ, Kirschner LS, Matyakhina L, Stergiopoulos SG, Robinson-White A, Lenherr SM, Weinberg FD, Claflin ES, Batista D, Bourdeau I, Voutetakis A, Sandrini F, Meoli EM, Bauer AJ, Cho-Chung YS, Bornstein SR, Carney JA, Stratakis CA 2004 A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumors: comparison with Carney complex and other PRKAR1A induced lesions. J Med Genet 41:923-931
8. Griffin KJ, Kirschner LS, Matyakhina L, Stergiopoulos S, Robinson-White A, Lenherr S, Weinberg FD, Claflin E, Meoli E, Cho-Chung YS, Stratakis CA 2004 Down-regulation of regulatory subunit type 1A of protein kinase A leads to endocrine and other tumors. Cancer Res 64:8811-8815
9. Kirschner LS, Kusewitt DF, Matyakhina L, Towns 2nd WH, Carney JA, Westphal H, Stratakis CA 2005 A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues. Cancer Res 65:4506-4514
10. Tasken K, Shalhegg BS, Tasken KA, Solberg R, Knutsen HK, Levy FO, Sandberg M, Orstavik S, Larsen T, Johansen AK, Vang T, Schrader HP, Reinton NT, Torgersen KM, Hansson V, Jahnsen T 1997 Structure, function and regulation of human cAMP-dependent protein kinase. Signal transduction in health and disease. In: Corbin J, Frances S, eds. Advances in second messenger and phosphoprotein research. Philadelphia: Lippencott-Raven; 191-204
11. Sidovar MF, Kozlowski P, Lee JW, Collins MA, He Y, Graves LM 2000 Phosphorylation of serine 43 is not required for inhibition of c-Raf kinase by the cAMP-dependent protein kinase. J Biol Chem 275:28688-28694
12. Houslay MD, Kolch W 2000 Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling. Mol Pharmacol 58:659-668
13. Pearson G, Robinson F, Beers GT, Xu BE, Karandikar M, Berman K, Cobb MH 2001 Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22:153-183
14. Robinson-White A, Stratakis CA 2002 Protein kinase A signaling: "cross talk" with other pathways in endocrine cells. Ann NY Acad Sci 968:256-270
15. Erhardt P, Troppmair J, Rapp UR, Cooper GM1995 Differential regulation of Raf-1 and B-raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells. Mol Cell Biol 15:5524-5530
16. Robinson-White A, Hundley TR, Shiferaw M, Bertherat J, Sandrini F, Stratakis CA 2003 Protein kinase-A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1/2. Hum Mol Genet 12:1475-1484
17. Amieux PS, Cummings DE, Motamed K, Brandon EP, Wailes LA, Le K Idzerda RL, McKnight GS1997 Compensatory regulation of RIα protein levels in protein kinase A mutant mice. J Biol Chem 272:3993-3998
18. Amieux PS, McKnight GS 2002 The essential role of RIα in the maintenance of regulated PKA activity. Ann NY Acad Sci 968:75-95
19. McKnight GS, Cummings DE, Amieux PS, Sikorski MA, Brandon EP, Planas JV, Motamed K, Idzerda RL 1998 Cyclic AMP, PKA, and the physiological regulation of adiposity. Recent Prog Horm Res 53:139-159
20. Guan K-L, Figueroa C, Brtva TR, Zhu T, Taylor J, Barber TD, Vojtek AB 2000 Negative regulation of the serine/threonine kinase B-raf by Akt. J Biol Chem 275:27354-27359
21. Jun T, Gjoerup O, Roberts TM 1999 Tangled webs: evidence of cross-talk between c-Raf-1 and Akt. Perspective 13:1-4
22. Bertherat J, Groussin L, Sandrini F, Matyakhina L, Bei T, Stergiopoulos S, Papageorgiou T, Bourdeau I, Kirschner LS, Vincent-Dejean C, Perlemoine K, Gicquel C, Bertagna X, Stratakis CA 2003 Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity. Cancer Res 63:5308-5319
23. Lepique AP, Moraes MS, Rocha KM, Eichler CB, Hajj GNM, Schwindt TT, Armelin HA 2004 c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells. J Mol Endocrinol 33:623-638
24. Costa ET, Forti FL Rocha KM, Moraes MS, Armelin, HA 2004 Molecular mechanisms of cell cycle control in the mouse Y1 adrenal cell line. Endocr Res 30:503-509
25. Lotfi CFP, Armelin HA 2001 cfos and cjun antisense oligonucleotides block mitogenesis triggered by fibroblast growth factor-2 and ACTH in mouse Y1 adrenocortical cells. J Endocrinol 168:381-389
26. kip1 induction in mouse Y1 adrenocortical tumor cells is dependent on both PKA activation and Akt/PKB inactivation. Biochem 41:10133-10140
27. Lotfi CFP, Todoronvic Z, Armelin HA, Schimmer BP 1997 Unmasking a growth-promoting effect of the adrenocorticotropic hormone in Y1 mouse adrenocortical tumor cells. J Biol Chem 272:29886-29891
28. Lotfi CFP, Lepique AP, Forti FL, Schwindt TT, Eichler CB, Santos MO, Rebustini IT, Hajj GNM, Juliano L, Armelin HA 2000 Proliferative signaling initiated in ACTH receptors. Braz J Med Biol Res 33:1133-1140
29. 1-arrested mouse Y1 adrenocortical cells stimulated by ACTH and FGF2. Endocrinol Res 26:825-832
30. Rocha KM, Forti FL, Lepique AP, Armelin HA 2003 Deconstructing the molecular mechanisms of cell cycle control in a mouse adrenocortical cell line: roles of ACTH. Microsc Res Tech 61:268-274
31. Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins JR 2000 Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev 14:2501-2514
32. Liang J, Slingerland JM 2003 Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2:339-345
33. Salghetti SE, Kim SY, Tansey WP 1999 Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J 18:717-726
34. Kops GJPL, Burgering MT 1999 Forkhead transcription factors: new insights into protein kinase B (c-act) signaling. J Mol Med 77:656-665
35. Mercer KE, Pritchard CA 2003 Raf proteins and cancer:B-raf is identified as a mutational target. Biochim Biophysics Acta 1653:25-40
36. Ferreira JG, Cruz C, Vinson G, Panatela D 2004 ACTH modulates ERK phosphorylation in the adrenal gland in a time-dependent manner. Endocr Res 30:661-666
37. Fassnacht M, Hahner S, Hansen IA, Kreutzberger T, Zink M, Adermann K, Jakob F, Troppmair J, Allolio B 2003 N-terminal proopiomelanocortin acts as a mitogen in adrenocortical tumor cells and decreases adrenal steroidogenesis. J Clin Endocrinol Metab 88:2171-2179
38. Lotfi CFP, Costa ET, Schwindt TT, Armelin HA 2000 Role of ERK/MAP kinase in mitogenic interaction between ACTH and FDGF2 in mouse Y1 adrenocortical tumor cells. Endocrinol Res 26:873-877
39. kip-1 expression. J Immunol 163:4140-4149
40. kip1 and cyclin D3 to suppress proliferation of leukemic T cell lines. J Biol Chem 276:33854-33860